Bea G Perez Nievas
banner
beagpereznievas.bsky.social
Bea G Perez Nievas
@beagpereznievas.bsky.social
Neuroscientist, I guess
Now Editor at @TheLancet. Before @NatureNeuro. In my other life Fellow @KingsCollegeLon and Fulbright postdoc at MGH, PhD from @unicomplutense Opinions my own
So cool to see it published!
May 22, 2025 at 8:34 PM
This Comment by Kim de Laat Sarah Kaplan and Lechin Lu on accelarating progress towards gender equity in health and science. So relevant for the topic.
www.thelancet.com/journals/lan...
Accelerating progress towards gender equity in health and science
Since 2000, women's representation in health professions has increased steadily across the globe. In 2019, nearly half of all doctors in countries in the Organisation for Economic Co-operation and Dev...
www.thelancet.com
February 11, 2025 at 5:13 PM
Farah Lunat (with Prof Husain) published the ROSHNI trial on an adapted CBT for British south Asian women with post natal depression
www.thelancet.com/journals/lan...
Efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women (ROSHNI-2): a multicentre, randomised controlled trial
In British south Asian women with postnatal depression, a culturally adapted group CBT-based intervention could aid in quicker recovery from depression compared with treatment as usual. Further resear...
www.thelancet.com
February 11, 2025 at 5:12 PM
Kari Johansson published this population study to investigate optimal weight gain/loss in pregnant women with obesity
www.thelancet.com/journals/lan...
Safety of low weight gain or weight loss in pregnancies with class 1, 2, and 3 obesity: a population-based cohort study
Our findings support calls to lower or remove the lower limit of current IOM recommendations for pregnant women with obesity, and suggest that separate guidelines for class 3 obesity might be warrante...
www.thelancet.com
February 11, 2025 at 5:12 PM
COMMEND trial by Becky Gould where they found that Acceptance Commitment Therapy improved quality of life in people with ALS. Such an important positive trial for the community
thelancet.com/pdfs/journal...
thelancet.com
February 11, 2025 at 5:11 PM